speb/financial-data huggingface dataset:
BCRX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 187906000.00
BCRX balance_sheet (annual, 2022-12-31) — Other Current Assets: 12586000.00
BCRX balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 26000.00
BCRX income_statement (annual, 2022-12-31) — Other Income Expense: -1983000.00
BCRX cash_flow (annual, 2022-12-31) — Other Non Cash Items: 98918000.00
BCRX balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 6806000.00
BCRX balance_sheet (annual, 2022-12-31) — Other Payable: 7700000.00
BCRX balance_sheet (annual, 2022-12-31) — Other Properties: 4588000.00
BCRX balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 119543000.00
BCRX balance_sheet (annual, 2022-12-31) — Payables: 22056000.00
BCRX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 65464000.00
BCRX balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 22125000.00
BCRX balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
BCRX income_statement (annual, 2022-12-31) — Pretax Income: -244383000.00
BCRX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 14765000.00
BCRX balance_sheet (annual, 2022-12-31) — Properties: 0.00
BCRX cash_flow (annual, 2022-12-31) — Purchase Of Investment: -244283000.00
BCRX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1351000.00
BCRX balance_sheet (annual, 2022-12-31) — Raw Materials: 8906000.00
BCRX balance_sheet (annual, 2022-12-31) — Receivables: 50599000.00
BCRX income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 6594000.00
BCRX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 1437000.00
BCRX cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
BCRX income_statement (annual, 2022-12-31) — Research And Development: 253297000.00
BCRX balance_sheet (annual, 2022-12-31) — Restricted Cash: 1472000.00
BCRX balance_sheet (annual, 2022-12-31) — Retained Earnings: -1454620000.00
BCRX cash_flow (annual, 2022-12-31) — Sale Of Investment: 117396000.00
BCRX income_statement (annual, 2022-12-31) — Selling General And Administration: 159371000.00
BCRX balance_sheet (annual, 2022-12-31) — Share Issued: 187906000.00
BCRX cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 73072000.00
BCRX cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
BCRX income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
BCRX cash_flow (annual, 2022-12-31) — Stock Based Compensation: 44701000.00
BCRX balance_sheet (annual, 2022-12-31) — Stockholders Equity: -294597000.00
BCRX balance_sheet (annual, 2022-12-31) — Tangible Book Value: -294597000.00
BCRX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -416430.00
BCRX income_statement (annual, 2022-12-31) — Tax Provision: 2733000.00
BCRX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
BCRX balance_sheet (annual, 2022-12-31) — Total Assets: 550000000.00
BCRX balance_sheet (annual, 2022-12-31) — Total Capitalization: 438682000.00
BCRX balance_sheet (annual, 2022-12-31) — Total Debt: 741452000.00
BCRX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -294597000.00
BCRX income_statement (annual, 2022-12-31) — Total Expenses: 419262000.00
BCRX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 844597000.00
BCRX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 33500000.00
BCRX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 739083000.00
BCRX income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -148435000.00
BCRX balance_sheet (annual, 2022-12-31) — Total Tax Payable: 410000.00
BCRX income_statement (annual, 2022-12-31) — Total Unusual Items: -1983000.00
BCRX income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -1983000.00
BCRX balance_sheet (annual, 2022-12-31) — Work In Process: 14990000.00
BCRX balance_sheet (annual, 2022-12-31) — Working Capital: 410986000.00
BCRX income_statement (annual, 2023-12-31) — +Operating Expense: 430640000.00
BCRX income_statement (annual, 2023-12-31) — +Total Revenue: 331412000.00
BCRX balance_sheet (annual, 2023-12-31) — Accounts Payable: 20893000.00
BCRX balance_sheet (annual, 2023-12-31) — Accounts Receivable: 56950000.00
BCRX balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -11210000.00
BCRX balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1222236000.00
BCRX cash_flow (annual, 2023-12-31) — Amortization Of Securities: -10263000.00
BCRX cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 1970000.00
BCRX income_statement (annual, 2023-12-31) — Basic Average Shares: 192198000.00
BCRX income_statement (annual, 2023-12-31) — Basic EPS: -1.18
BCRX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 306239000.00
BCRX cash_flow (annual, 2023-12-31) — Capital Expenditure: -2168000.00
BCRX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 13883000.00
BCRX balance_sheet (annual, 2023-12-31) — Capital Stock: 2058000.00
BCRX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 110643000.00
BCRX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 388987000.00
BCRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 32485000.00
BCRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -131498000.00
BCRX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -95141000.00
BCRX cash_flow (annual, 2023-12-31) — Change In Account Payable: 12531000.00
BCRX cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 0.00
BCRX cash_flow (annual, 2023-12-31) — Change In Interest Payable: 0.00
BCRX cash_flow (annual, 2023-12-31) — Change In Inventory: -1450000.00
BCRX cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -29337000.00
BCRX cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -1230000.00
BCRX cash_flow (annual, 2023-12-31) — Change In Payable: 12531000.00
BCRX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 12531000.00
BCRX cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -6820000.00
BCRX cash_flow (annual, 2023-12-31) — Change In Receivables: -6095000.00
BCRX cash_flow (annual, 2023-12-31) — Change In Working Capital: -32401000.00
BCRX cash_flow (annual, 2023-12-31) — Changes In Cash: -194154000.00
BCRX balance_sheet (annual, 2023-12-31) — Common Stock: 2058000.00
BCRX balance_sheet (annual, 2023-12-31) — Common Stock Equity: -455528000.00
BCRX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 342000.00
BCRX balance_sheet (annual, 2023-12-31) — Construction In Progress: 0.00
BCRX income_statement (annual, 2023-12-31) — Cost Of Revenue: 4481000.00
BCRX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 21331000.00
BCRX balance_sheet (annual, 2023-12-31) — Current Assets: 495966000.00
BCRX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 2648000.00
BCRX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 2648000.00
BCRX balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 0.00
BCRX balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 0.00
BCRX balance_sheet (annual, 2023-12-31) — Current Liabilities: 149988000.00
BCRX balance_sheet (annual, 2023-12-31) — Current Provisions: 26509000.00
BCRX cash_flow (annual, 2023-12-31) — Depreciation: 1655000.00
BCRX cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 1655000.00
BCRX cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1655000.00
BCRX income_statement (annual, 2023-12-31) — Diluted Average Shares: 192198000.00
BCRX income_statement (annual, 2023-12-31) — Diluted EPS: -1.18
BCRX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -226539000.00
BCRX income_statement (annual, 2023-12-31) — EBIT: -117990000.00
BCRX income_statement (annual, 2023-12-31) — EBITDA: -116335000.00
BCRX cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 0.00
BCRX cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 362000.00
BCRX cash_flow (annual, 2023-12-31) — End Cash Position: 112447000.00
BCRX cash_flow (annual, 2023-12-31) — Financing Cash Flow: 32485000.00
BCRX balance_sheet (annual, 2023-12-31) — Finished Goods: 6242000.00
BCRX cash_flow (annual, 2023-12-31) — Free Cash Flow: -97309000.00
BCRX cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
BCRX income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -1039000.00
BCRX balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 1337000.00
BCRX balance_sheet (annual, 2023-12-31) — Gross PPE: 32124000.00
BCRX income_statement (annual, 2023-12-31) — Gross Profit: 326931000.00
BCRX cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 1434000.00
BCRX income_statement (annual, 2023-12-31) — Interest Expense: 108239000.00
BCRX income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 108239000.00
BCRX income_statement (annual, 2023-12-31) — Interest Income: 15777000.00
BCRX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 15777000.00
BCRX cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 22139000.00
BCRX balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -1599000.00
BCRX balance_sheet (annual, 2023-12-31) — Inventory: 28683000.00
BCRX balance_sheet (annual, 2023-12-31) — Invested Capital: 355737000.00
BCRX cash_flow (annual, 2023-12-31) — Investing Cash Flow: -131498000.00
BCRX balance_sheet (annual, 2023-12-31) — Investments And Advances: 0.00
BCRX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 342000.00
BCRX cash_flow (annual, 2023-12-31) — Issuance Of Debt: 300000000.00
BCRX balance_sheet (annual, 2023-12-31) — Leases: 10206000.00
BCRX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 11235000.00
BCRX balance_sheet (annual, 2023-12-31) — Long Term Debt: 811265000.00
BCRX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 822500000.00
BCRX cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 300000000.00
BCRX cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -241617000.00
BCRX balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 3355000.00
BCRX cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
BCRX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 342000.00
BCRX balance_sheet (annual, 2023-12-31) — Net Debt: 700622000.00
BCRX income_statement (annual, 2023-12-31) — Net Income: -226539000.00
BCRX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -226539000.00
BCRX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -226539000.00
BCRX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -226539000.00
BCRX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -226539000.00
BCRX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -226539000.00
BCRX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -226539000.00
BCRX income_statement (annual, 2023-12-31) — Net Interest Income: -92462000.00
BCRX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -129330000.00
BCRX cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 58383000.00
BCRX cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 58383000.00
BCRX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -92462000.00
BCRX cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -34580000.00
BCRX balance_sheet (annual, 2023-12-31) — Net PPE: 20914000.00
BCRX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -2168000.00
BCRX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -455528000.00
BCRX income_statement (annual, 2023-12-31) — Normalized EBITDA: -86277000.00
BCRX income_statement (annual, 2023-12-31) — Normalized Income: -202793180.00
BCRX cash_flow (annual, 2023-12-31) — Operating Cash Flow: -95141000.00
BCRX cash_flow (annual, 2023-12-31) — Operating Gains Losses: 29019000.00
BCRX income_statement (annual, 2023-12-31) — Operating Income: -103709000.00
BCRX income_statement (annual, 2023-12-31) — Operating Revenue: 331412000.00
BCRX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 205771000.00
BCRX balance_sheet (annual, 2023-12-31) — Other Current Assets: 19542000.00
BCRX balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 23565000.00
BCRX balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 1337000.00
BCRX income_statement (annual, 2023-12-31) — Other Income Expense: -30058000.00
BCRX cash_flow (annual, 2023-12-31) — Other Non Cash Items: 85803000.00
BCRX balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 80000.00
BCRX balance_sheet (annual, 2023-12-31) — Other Payable: 18524000.00
BCRX balance_sheet (annual, 2023-12-31) — Other Properties: 18563000.00
BCRX balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 278344000.00
BCRX income_statement (annual, 2023-12-31) — Other Special Charges: 29019000.00
BCRX balance_sheet (annual, 2023-12-31) — Payables: 39417000.00
BCRX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 60748000.00
BCRX balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 36518000.00
BCRX balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
BCRX income_statement (annual, 2023-12-31) — Pretax Income: -226229000.00
BCRX cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 8340000.00
BCRX balance_sheet (annual, 2023-12-31) — Properties: 0.00
BCRX cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
BCRX cash_flow (annual, 2023-12-31) — Purchase Of Investment: -514407000.00
BCRX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -2168000.00
BCRX balance_sheet (annual, 2023-12-31) — Raw Materials: 6449000.00
BCRX balance_sheet (annual, 2023-12-31) — Receivables: 56950000.00
BCRX income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 4481000.00
BCRX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1655000.00
BCRX cash_flow (annual, 2023-12-31) — Repayment Of Debt: -241617000.00
BCRX income_statement (annual, 2023-12-31) — Research And Development: 216566000.00
BCRX balance_sheet (annual, 2023-12-31) — Restricted Cash: 1804000.00
BCRX balance_sheet (annual, 2023-12-31) — Retained Earnings: -1681159000.00
BCRX cash_flow (annual, 2023-12-31) — Sale Of Investment: 385077000.00
BCRX income_statement (annual, 2023-12-31) — Selling General And Administration: 214074000.00
BCRX balance_sheet (annual, 2023-12-31) — Share Issued: 205771000.00
BCRX income_statement (annual, 2023-12-31) — Special Income Charges: -29019000.00
BCRX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 55615000.00
BCRX balance_sheet (annual, 2023-12-31) — Stockholders Equity: -455528000.00
BCRX balance_sheet (annual, 2023-12-31) — Tangible Book Value: -455528000.00
BCRX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -6312180.00
BCRX income_statement (annual, 2023-12-31) — Tax Provision: 310000.00
BCRX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
BCRX balance_sheet (annual, 2023-12-31) — Total Assets: 516960000.00
BCRX balance_sheet (annual, 2023-12-31) — Total Capitalization: 355737000.00
BCRX balance_sheet (annual, 2023-12-31) — Total Debt: 825148000.00
BCRX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -455528000.00
BCRX income_statement (annual, 2023-12-31) — Total Expenses: 435121000.00
BCRX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 972488000.00
BCRX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 20994000.00
BCRX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 822500000.00
BCRX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -103709000.00
BCRX income_statement (annual, 2023-12-31) — Total Unusual Items: -30058000.00
BCRX income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -30058000.00
BCRX balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
BCRX balance_sheet (annual, 2023-12-31) — Work In Process: 17591000.00
BCRX balance_sheet (annual, 2023-12-31) — Working Capital: 345978000.00
BCRX cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 1361000.00
BCRX cash_flow (quarterly, 2024-09-30) — Changes In Cash: 18008000.00
BCRX cash_flow (quarterly, 2024-09-30) — End Cash Position: 99064000.00
BCRX cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 360000.00
BCRX cash_flow (quarterly, 2024-09-30) — Interest Paid Supplemental Data: 10201000.00
BCRX cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
BCRX cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
BCRX income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
BCRX income_statement (annual, 2024-12-31) — +Operating Expense: 440986000.00
BCRX income_statement (annual, 2024-12-31) — +Total Revenue: 450712000.00
BCRX balance_sheet (annual, 2024-12-31) — Accounts Payable: 11644000.00
BCRX balance_sheet (annual, 2024-12-31) — Accounts Receivable: 79069000.00
BCRX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -12349000.00
BCRX balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -12349000.00
BCRX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1291100000.00
BCRX cash_flow (annual, 2024-12-31) — Amortization Of Securities: -11473000.00
BCRX cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 1350000.00
BCRX cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: -11000.00
BCRX income_statement (annual, 2024-12-31) — Basic Average Shares: 206696000.00
BCRX income_statement (annual, 2024-12-31) — Basic EPS: -0.43
BCRX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 112447000.00
BCRX cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 99064000.00
BCRX cash_flow (annual, 2024-12-31) — Capital Expenditure: -1124000.00
BCRX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 12820000.00
BCRX balance_sheet (annual, 2024-12-31) — Capital Stock: 2085000.00
BCRX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 104713000.00
BCRX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 320850000.00
BCRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -5761000.00
BCRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 52593000.00
BCRX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -52020000.00
BCRX cash_flow (annual, 2024-12-31) — Change In Account Payable: 14776000.00
BCRX cash_flow (quarterly, 2024-12-31) — Change In Account Payable: -2446000.00
BCRX cash_flow (annual, 2024-12-31) — Change In Inventory: -4164000.00
BCRX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -77155000.00
BCRX cash_flow (annual, 2024-12-31) — Change In Payable: 14776000.00
BCRX cash_flow (quarterly, 2024-12-31) — Change In Payable: -2446000.00
BCRX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 14776000.00
BCRX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 1959000.00
BCRX cash_flow (annual, 2024-12-31) — Change In Receivables: -22698000.00
BCRX cash_flow (annual, 2024-12-31) — Change In Working Capital: -87282000.00
BCRX cash_flow (annual, 2024-12-31) — Changes In Cash: -5188000.00
BCRX cash_flow (quarterly, 2024-12-31) — Changes In Cash: 8563000.00
BCRX balance_sheet (annual, 2024-12-31) — Common Stock: 2085000.00
BCRX balance_sheet (annual, 2024-12-31) — Common Stock Equity: -475934000.00
BCRX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 34000.00
BCRX balance_sheet (annual, 2024-12-31) — Construction In Progress: 97000.00
BCRX balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 97000.00
BCRX income_statement (annual, 2024-12-31) — Cost Of Revenue: 12269000.00
BCRX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 17955000.00
BCRX balance_sheet (annual, 2024-12-31) — Current Assets: 421968000.00
BCRX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 2772000.00
BCRX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 2772000.00
BCRX balance_sheet (annual, 2024-12-31) — Current Liabilities: 160384000.00
BCRX balance_sheet (annual, 2024-12-31) — Current Provisions: 32116000.00
BCRX balance_sheet (quarterly, 2024-12-31) — Current Provisions: 32116000.00
BCRX cash_flow (annual, 2024-12-31) — Depreciation: 1246000.00
BCRX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1246000.00
BCRX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1246000.00
BCRX income_statement (annual, 2024-12-31) — Diluted Average Shares: 206696000.00
BCRX income_statement (annual, 2024-12-31) — Diluted EPS: -0.43
BCRX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -88881000.00
BCRX income_statement (annual, 2024-12-31) — EBIT: 11562000.00
BCRX income_statement (annual, 2024-12-31) — EBITDA: 12808000.00
BCRX cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 0.00
BCRX cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -936000.00
BCRX cash_flow (annual, 2024-12-31) — End Cash Position: 106323000.00
BCRX cash_flow (quarterly, 2024-12-31) — End Cash Position: 106323000.00
BCRX cash_flow (annual, 2024-12-31) — Financing Cash Flow: -5761000.00
BCRX balance_sheet (annual, 2024-12-31) — Finished Goods: 7765000.00
BCRX balance_sheet (quarterly, 2024-12-31) — Finished Goods: 7765000.00
BCRX cash_flow (annual, 2024-12-31) — Free Cash Flow: -53144000.00
BCRX cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
BCRX income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -641000.00
BCRX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 921000.00
BCRX balance_sheet (annual, 2024-12-31) — Gross PPE: 32134000.00
BCRX income_statement (annual, 2024-12-31) — Gross Profit: 438443000.00
BCRX cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 1603000.00
BCRX cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 378000.00
BCRX income_statement (annual, 2024-12-31) — Interest Expense: 98516000.00
BCRX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 98516000.00
BCRX income_statement (annual, 2024-12-31) — Interest Income: 14746000.00
BCRX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 14746000.00
BCRX cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 30383000.00
BCRX cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 10141000.00
BCRX balance_sheet (annual, 2024-12-31) — Inventories Adjustments Allowances: -2649000.00
BCRX balance_sheet (quarterly, 2024-12-31) — Inventories Adjustments Allowances: -2649000.00
BCRX balance_sheet (annual, 2024-12-31) — Inventory: 8087000.00
BCRX balance_sheet (annual, 2024-12-31) — Invested Capital: 319988000.00
BCRX cash_flow (annual, 2024-12-31) — Investing Cash Flow: 52593000.00
BCRX balance_sheet (annual, 2024-12-31) — Investments And Advances: 20323000.00
BCRX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 34000.00
BCRX cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
BCRX cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
BCRX balance_sheet (annual, 2024-12-31) — Leases: 10363000.00
BCRX balance_sheet (quarterly, 2024-12-31) — Leases: 10363000.00
BCRX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 10048000.00
BCRX balance_sheet (annual, 2024-12-31) — Long Term Debt: 795922000.00
BCRX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 805970000.00
BCRX cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
BCRX cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
BCRX cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -1704000.00
BCRX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 3444000.00
BCRX balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 3444000.00
BCRX cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
BCRX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 34000.00
BCRX balance_sheet (annual, 2024-12-31) — Net Debt: 691209000.00
BCRX income_statement (annual, 2024-12-31) — Net Income: -88881000.00
BCRX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -88881000.00
BCRX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -88881000.00
BCRX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -88881000.00
BCRX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -88881000.00
BCRX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -88881000.00
BCRX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -88881000.00
BCRX income_statement (annual, 2024-12-31) — Net Interest Income: -83770000.00
BCRX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 53717000.00
BCRX cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -1704000.00
BCRX cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -1704000.00
BCRX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -83770000.00
BCRX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -7535000.00
BCRX balance_sheet (annual, 2024-12-31) — Net PPE: 19785000.00
BCRX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1124000.00
BCRX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -475934000.00
BCRX income_statement (annual, 2024-12-31) — Normalized EBITDA: 13449000.00
BCRX income_statement (annual, 2024-12-31) — Normalized Income: -88374610.00
BCRX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -52020000.00
BCRX income_statement (annual, 2024-12-31) — Operating Income: -2543000.00
BCRX income_statement (annual, 2024-12-31) — Operating Revenue: 450712000.00
BCRX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 208543452.00
BCRX balance_sheet (annual, 2024-12-31) — Other Current Assets: 13752000.00
BCRX balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 32676000.00
BCRX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 921000.00
BCRX income_statement (annual, 2024-12-31) — Other Income Expense: -641000.00
BCRX balance_sheet (annual, 2024-12-31) — Other Inventories: -23187000.00
BCRX balance_sheet (quarterly, 2024-12-31) — Other Inventories: -23187000.00
BCRX cash_flow (annual, 2024-12-31) — Other Non Cash Items: 67607000.00
BCRX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 28344000.00
BCRX balance_sheet (annual, 2024-12-31) — Other Payable: 14590000.00
BCRX balance_sheet (quarterly, 2024-12-31) — Other Payable: 14590000.00
BCRX balance_sheet (annual, 2024-12-31) — Other Properties: 18230000.00
BCRX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 216137000.00
BCRX balance_sheet (annual, 2024-12-31) — Payables: 26234000.00
BCRX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 44189000.00
BCRX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 48631000.00
BCRX balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 48631000.00
BCRX balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
BCRX income_statement (annual, 2024-12-31) — Pretax Income: -86954000.00
BCRX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 3444000.00
BCRX balance_sheet (annual, 2024-12-31) — Properties: 0.00
BCRX balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
BCRX cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
BCRX cash_flow (annual, 2024-12-31) — Purchase Of Investment: -266763000.00
BCRX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1124000.00
BCRX balance_sheet (annual, 2024-12-31) — Raw Materials: 10006000.00
BCRX balance_sheet (quarterly, 2024-12-31) — Raw Materials: 10006000.00
BCRX balance_sheet (annual, 2024-12-31) — Receivables: 79069000.00
BCRX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 12269000.00
BCRX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1246000.00
BCRX cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1704000.00
BCRX income_statement (annual, 2024-12-31) — Research And Development: 174638000.00
BCRX balance_sheet (annual, 2024-12-31) — Restricted Cash: 210000.00
BCRX balance_sheet (annual, 2024-12-31) — Retained Earnings: -1770040000.00
BCRX cash_flow (annual, 2024-12-31) — Sale Of Investment: 320480000.00
BCRX income_statement (annual, 2024-12-31) — Selling General And Administration: 266348000.00
BCRX balance_sheet (annual, 2024-12-31) — Share Issued: 208543452.00
BCRX income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
BCRX income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
BCRX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 65413000.00
BCRX balance_sheet (annual, 2024-12-31) — Stockholders Equity: -475934000.00
BCRX balance_sheet (annual, 2024-12-31) — Tangible Book Value: -475934000.00
BCRX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -134610.00
BCRX income_statement (annual, 2024-12-31) — Tax Provision: 1927000.00
BCRX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
BCRX balance_sheet (annual, 2024-12-31) — Total Assets: 490420000.00
BCRX balance_sheet (annual, 2024-12-31) — Total Capitalization: 319988000.00
BCRX balance_sheet (annual, 2024-12-31) — Total Debt: 808742000.00
BCRX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -475934000.00
BCRX income_statement (annual, 2024-12-31) — Total Expenses: 453255000.00
BCRX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 966354000.00
BCRX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 68452000.00
BCRX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 805970000.00
BCRX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -2543000.00
BCRX income_statement (annual, 2024-12-31) — Total Unusual Items: -641000.00
BCRX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -641000.00
BCRX balance_sheet (annual, 2024-12-31) — Work In Process: 16152000.00
BCRX balance_sheet (quarterly, 2024-12-31) — Work In Process: 16152000.00
BCRX balance_sheet (annual, 2024-12-31) — Working Capital: 261584000.00
BCRX income_statement (quarterly, 2025-03-31) — +Operating Expense: 119739000.00
BCRX income_statement (quarterly, 2025-03-31) — +Total Revenue: 145534000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 10049000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 93394000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1314857000.00
BCRX cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -1383000.00
BCRX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 208882000.00
BCRX income_statement (quarterly, 2025-03-31) — Basic EPS: 0.00
BCRX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 106323000.00
BCRX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -143000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 12959000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2092000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 105190000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 295092000.00
BCRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 529000.00
BCRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 27095000.00
BCRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -27517000.00
BCRX cash_flow (quarterly, 2025-03-31) — Change In Inventory: -870000.00
BCRX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -14549000.00
BCRX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -32594000.00
BCRX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -132000.00
BCRX cash_flow (quarterly, 2025-03-31) — Change In Receivables: -13987000.00
BCRX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -62132000.00
BCRX cash_flow (quarterly, 2025-03-31) — Changes In Cash: 107000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Common Stock: 2092000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -451927000.00
BCRX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 6000.00
BCRX income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 4568000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 92635000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Current Assets: 409977000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 2866000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 2866000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 139855000.00
BCRX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 331000.00
BCRX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 331000.00
BCRX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 215261000.00
BCRX income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
BCRX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 32000.00
BCRX income_statement (quarterly, 2025-03-31) — EBIT: 24252000.00
BCRX income_statement (quarterly, 2025-03-31) — EBITDA: 24583000.00
BCRX cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 451000.00
BCRX cash_flow (quarterly, 2025-03-31) — End Cash Position: 106881000.00
BCRX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 529000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Finished Goods: 7887000.00
BCRX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -27660000.00
BCRX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 1000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 1132000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 19575000.00
BCRX income_statement (quarterly, 2025-03-31) — Gross Profit: 140966000.00
BCRX cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 1000.00
BCRX income_statement (quarterly, 2025-03-31) — Interest Expense: 23494000.00
BCRX income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 23494000.00
BCRX income_statement (quarterly, 2025-03-31) — Interest Income: 3024000.00
BCRX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 3024000.00
BCRX cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 9153000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Inventories Adjustments Allowances: -2085000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Inventory: 6873000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 330099000.00
BCRX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 27095000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 20548000.00
BCRX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 6000.00
BCRX cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
BCRX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 10093000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 782026000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 792119000.00
BCRX cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
BCRX cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -516000.00
BCRX cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
BCRX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 6000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Net Debt: 676836000.00
BCRX income_statement (quarterly, 2025-03-31) — Net Income: 32000.00
BCRX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 32000.00
BCRX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 32000.00
BCRX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 32000.00
BCRX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 32000.00
BCRX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 32000.00
BCRX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 32000.00
BCRX income_statement (quarterly, 2025-03-31) — Net Interest Income: -20470000.00
BCRX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 27238000.00
BCRX cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -516000.00
BCRX cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -516000.00
BCRX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -20470000.00
BCRX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1351000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Net PPE: 19575000.00
BCRX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -143000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -451927000.00
BCRX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 24582000.00
BCRX income_statement (quarterly, 2025-03-31) — Normalized Income: 31210.00
BCRX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -27517000.00
BCRX income_statement (quarterly, 2025-03-31) — Operating Income: 21227000.00
BCRX income_statement (quarterly, 2025-03-31) — Operating Revenue: 134243000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 209208000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 14327000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 34305000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 1132000.00
BCRX income_statement (quarterly, 2025-03-31) — Other Income Expense: 1000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Other Inventories: -25097000.00
BCRX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 14267000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 29947000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Other Properties: 19575000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 189902000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Payables: 10049000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 102684000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
BCRX income_statement (quarterly, 2025-03-31) — Pretax Income: 758000.00
BCRX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 2390000.00
BCRX cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
BCRX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -48762000.00
BCRX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -143000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Raw Materials: 8742000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Receivables: 93394000.00
BCRX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 4568000.00
BCRX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 331000.00
BCRX cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -516000.00
BCRX income_statement (quarterly, 2025-03-31) — Research And Development: 37270000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 291000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1770008000.00
BCRX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 76000000.00
BCRX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 82469000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Share Issued: 209208000.00
BCRX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 21368000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -451927000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -451927000.00
BCRX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 210.00
BCRX income_statement (quarterly, 2025-03-31) — Tax Provision: 726000.00
BCRX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
BCRX balance_sheet (quarterly, 2025-03-31) — Total Assets: 480047000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 330099000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Total Debt: 794985000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -451927000.00
BCRX income_statement (quarterly, 2025-03-31) — Total Expenses: 124307000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 931974000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 70070000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 792119000.00
BCRX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 21227000.00
BCRX income_statement (quarterly, 2025-03-31) — Total Unusual Items: 1000.00
BCRX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 1000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Work In Process: 17426000.00
BCRX balance_sheet (quarterly, 2025-03-31) — Working Capital: 270122000.00
BCRX income_statement (quarterly, 2025-06-30) — +Operating Expense: 130769000.00
BCRX income_statement (quarterly, 2025-06-30) — +Total Revenue: 163353000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 8589000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 91177000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1339584000.00
BCRX cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -1150000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 29170000.00
BCRX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 209519000.00
BCRX income_statement (quarterly, 2025-06-30) — Basic EPS: 0.02
BCRX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 106881000.00
BCRX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -179000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 12540000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2099000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 88033000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 260038000.00
BCRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -73686000.00
BCRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 29127000.00
BCRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 41302000.00
BCRX cash_flow (quarterly, 2025-06-30) — Change In Inventory: 1438000.00
BCRX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -22372000.00
BCRX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 30459000.00
BCRX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 160000.00
BCRX cash_flow (quarterly, 2025-06-30) — Change In Receivables: -7308000.00
BCRX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 2377000.00
BCRX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -3257000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Common Stock: 2099000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -421594000.00
BCRX cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 9000.00
BCRX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2798000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 107114000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Current Assets: 398462000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 2008000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 2008000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 177160000.00
BCRX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 329000.00
BCRX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 329000.00
BCRX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 219886000.00
BCRX income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.02
BCRX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 5085000.00
BCRX income_statement (quarterly, 2025-06-30) — EBIT: 28068000.00
BCRX income_statement (quarterly, 2025-06-30) — EBITDA: 28397000.00
BCRX cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 1359000.00
BCRX cash_flow (quarterly, 2025-06-30) — End Cash Position: 89925000.00
BCRX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -73686000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Finished Goods: 5965000.00
BCRX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 41123000.00
BCRX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -63000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 1646000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 20003000.00
BCRX income_statement (quarterly, 2025-06-30) — Gross Profit: 160555000.00
BCRX cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 1227000.00
BCRX income_statement (quarterly, 2025-06-30) — Interest Expense: 21582000.00
BCRX income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 21582000.00
BCRX income_statement (quarterly, 2025-06-30) — Interest Income: 2516000.00
BCRX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 2516000.00
BCRX cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 7526000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Inventories Adjustments Allowances: -1911000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Inventory: 5044000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 269042000.00
BCRX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 29127000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 10101000.00
BCRX cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 9000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Liabilities Heldfor Sale Non Current: 454000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 10532000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 690636000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 701168000.00
BCRX cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -70044000.00
BCRX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 9000.00
BCRX balance_sheet (quarterly, 2025-06-30) — Net Debt: 602603000.00
BCRX income_statement (quarterly, 2025-06-30) — Net Income: 5085000.00
BCRX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 5085000.00
BCRX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 5085000.00
BCRX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 5085000.00
BCRX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 5085000.00
BCRX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 5085000.00
BCRX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 5085000.00
BCRX income_statement (quarterly, 2025-06-30) — Net Interest Income: -19066000.00
BCRX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 29306000.00